Cargando…
Relationship between homologous recombination deficiency and clinical features of breast cancer based on genomic scar score()
BACKGROUND: Homologous recombination deficiency (HRD) phenotype will sensitize tumors to poly (ADP-ribose) polymerases inhibitors and platinum. However, previous studies did not focus on the prevalence of HRD among Chinese breast cancer (BC) patients. METHODS: One hundred and forty-seven BC patients...
Autores principales: | Feng, Cong, Zhang, Yinbin, Wu, Fei, Li, Jia, Liu, Mengjie, Lv, Wei, Li, Chaofan, Wang, Weiwei, Tan, Qinghua, Xue, Xiaoyu, Ma, Xingcong, Zhang, Shuqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165146/ https://www.ncbi.nlm.nih.gov/pubmed/37116400 http://dx.doi.org/10.1016/j.breast.2023.04.002 |
Ejemplares similares
-
HRD-MILN: Accurately estimate tumor homologous recombination deficiency status from targeted panel sequencing data
por: Wang, Xuwen, et al.
Publicado: (2022) -
Homologous Recombination Deficiency Scar: Mutations and Beyond—Implications for Precision Oncology
por: van der Wiel, Alexander M. A., et al.
Publicado: (2022) -
Machine learning predicts the prognosis of breast cancer patients with initial bone metastases
por: Li, Chaofan, et al.
Publicado: (2022) -
Relationship between metastasis and second primary cancers in women with breast cancer
por: Li, Chaofan, et al.
Publicado: (2022) -
A novel hypoxia- and lactate metabolism-related signature to predict prognosis and immunotherapy responses for breast cancer by integrating machine learning and bioinformatic analyses
por: Li, Jia, et al.
Publicado: (2022)